tezspire
astrazeneca ab - tezepelumab - astm - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
tezspire 210 mg
astrazeneca ab - suedia - tezepelumabum - sol. inj. in seringa preumpluta - 110mg/ml - alte med. pt. trat. bolilor obstructive ale c.r, sistemice alte med. pt. trat. bolilor obstructive ale c.r, sistemice
tezspire 210 mg
astrazeneca ab - suedia - tezepelumabum - sol. inj. in stilou injector (pen) preumplut - 110mg/ml - alte med. pt. trat. bolilor obstructive ale c.r, sistemice alte med. pt. trat. bolilor obstructive ale c.r, sistemice